Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals. Journal of Pharmaceutical Negative Results 2022, 921-929. https://doi.org/10.47750/pnr.2022.13.S09.110.